Healthcare, like life, is very much easier when you have options.  Being able to pick and choose what remedy might work in particular circumstances both increases the overall chances of success and can provide more elegant and tailored solutions.  It’s with this overall philosophy in mind that any new drug should be welcomed to the market. One such drug is semaglutide, a new medication hailed as a ‘game-changer’ in the treatment of obesity. 

Read more...

Scientists may have just added a new variable to the who, what, where and how of exercise.  Rather than looking at how we exercise, or what equipment we use, boffins at the Netherlands Cardiovascular Research Institute have decided to study what difference ‘when’ might make.

Read more...

What does the future hold in healthcare in the long-term?  At the end of last year we brought you the first half of accountancy giant Deloitte’s series on the future of healthcare. In the second and final chapter, we look at key developments such as advances in pharmaceutical research and development, improvements in supply chains and even how global warming will affect healthcare.

Read more...

If ever there was a year to invest in healthcare, it is going to be 2021.  After the year we’ve just had, focussing on our health and well-being is going to be key. (med)24's journal takes a look at the health trends for the year ahead.

Read more...